hotspot -WSS

hotspot

author：explore 2025-09-28 00:49:27 - browse：9

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Questions loom on AstraZeneca cancer drug as safety concerns ebb

WSS

STAT Readout Newsletter: Biotech news today

5 shark bites reported on Long Island as officials deploy surveillance drones

Readout LOUD podcast: Live from the 2023 STAT Summit

STAT Readout Newsletter: Biotech news today

UnitedHealth, Optum discontinue NaviHealth name

Adele warns fans about throwing things at performers onstage

focus

hotspot

focus

23andMe had bad news about my health. I wish a person had delivered it

2 million sign

Dobbs anniversary: the lost opportunity of abortion as health care

Is there really a nursing shortage in the U.S.?

Virginia high school admissions case could be legal follow

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Sports medicine is finally prioritizing gender equality

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

focus

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Condition critical? Britain's beloved but battered National Health Service turns 75

Smaller biotechs seek to piggyback on weight loss drug boom

EU moves toward latest gene techniques in food production to counter climate change, shortages

hotspot

hotspot

knowledge

hotspot